NASDAQ:KZR

Kezar Life Sciences News Headlines

$6.20
+0.44 (+7.64 %)
(As of 04/14/2021 03:59 PM ET)
Add
Compare
Today's Range
$5.95
Now: $6.20
$6.28
50-Day Range
$5.48
MA: $6.11
$6.80
52-Week Range
$4.00
Now: $6.20
$9.79
Volume10,538 shs
Average Volume281,997 shs
Market Capitalization$298.01 million
P/E RatioN/A
Dividend YieldN/A
Beta0.33

Headlines

Kezar Life Sciences (NASDAQ KZR) News Headlines Today

SourceHeadline
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual MeetingKezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting
finance.yahoo.com - April 10 at 8:46 AM
Zacks: Brokerages Expect Kezar Life Sciences, Inc. (NASDAQ:KZR) Will Post Earnings of -$0.24 Per ShareZacks: Brokerages Expect Kezar Life Sciences, Inc. (NASDAQ:KZR) Will Post Earnings of -$0.24 Per Share
americanbankingnews.com - March 30 at 4:36 PM
Kezar Life Sciences reports Q4 resultsKezar Life Sciences reports Q4 results
seekingalpha.com - March 13 at 3:02 AM
Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business UpdatesKezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates
finance.yahoo.com - March 11 at 8:33 PM
Kezar Life Sciences to Participate at Cowen 41st Annual Virtual Health Care ConferenceKezar Life Sciences to Participate at Cowen 41st Annual Virtual Health Care Conference
finance.yahoo.com - February 25 at 8:34 PM
What Kind Of Investors Own Most Of Kezar Life Sciences, Inc. (NASDAQ:KZR)?What Kind Of Investors Own Most Of Kezar Life Sciences, Inc. (NASDAQ:KZR)?
finance.yahoo.com - February 16 at 8:04 AM
Kezar Life Sciences to Present at BIO CEO & Investor Digital ConferenceKezar Life Sciences to Present at BIO CEO & Investor Digital Conference
finance.yahoo.com - February 10 at 7:15 PM
Kezar Life Sciences to Present at H.C. Wainwright Virtual BioConnect ConferenceKezar Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference
finance.yahoo.com - January 7 at 8:03 PM
Kezar Life Sciences, Inc. (NASDAQ:KZR) Insiders Increased Their HoldingsKezar Life Sciences, Inc. (NASDAQ:KZR) Insiders Increased Their Holdings
finance.yahoo.com - December 18 at 1:52 PM
Kezar Life Sciences Added to the Nasdaq Biotechnology IndexKezar Life Sciences Added to the Nasdaq Biotechnology Index
finance.yahoo.com - December 14 at 7:07 PM
Is KZR A Good Stock To Buy Now?Is KZR A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 2:06 PM
Kezar Life Sciences to Present During Upcoming Virtual Investor ConferencesKezar Life Sciences to Present During Upcoming Virtual Investor Conferences
finance.yahoo.com - November 12 at 5:55 PM
Kezar Life Sciences: Keyed In On Autoimmune TherapiesKezar Life Sciences: Keyed In On Autoimmune Therapies
seekingalpha.com - November 8 at 1:14 PM
Kezar Life Sciences EPS misses by $0.02Kezar Life Sciences EPS misses by $0.02
seekingalpha.com - November 5 at 8:30 PM
Kezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business UpdatesKezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business Updates
finance.yahoo.com - November 5 at 8:30 PM
Kezar Highlights Broad Therapeutic Potential of KZR-616 During ACR Convergence 2020Kezar Highlights Broad Therapeutic Potential of KZR-616 During ACR Convergence 2020
finance.yahoo.com - November 5 at 3:25 PM
Kezar Life Sciences KZR-616 an Orphan Drug in U.S. for autoimmune inflammatory disordersKezar Life Sciences' KZR-616 an Orphan Drug in U.S. for autoimmune inflammatory disorders
seekingalpha.com - October 23 at 7:57 AM
Kezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis and DermatomyositisKezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis and Dermatomyositis
finance.yahoo.com - October 23 at 7:57 AM
KEZAR LIFE SCIENC.DL-,001 (2KZ.MU)KEZAR LIFE SCIENC.DL-,001 (2KZ.MU)
au.finance.yahoo.com - October 12 at 5:33 PM
Kezar Life Sciences Inc. Regist (2KZ.SG)Kezar Life Sciences Inc. Regist (2KZ.SG)
au.finance.yahoo.com - October 10 at 7:16 AM
The Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO PresentationsThe Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO Presentations
finance.yahoo.com - September 18 at 12:28 PM
Encouraging lupus data lifts Kezar Life Sciences, up 9% after hoursEncouraging lupus data lifts Kezar Life Sciences, up 9% after hours
seekingalpha.com - September 17 at 8:35 PM
Kezar Highlights Data from MISSION Phase 1b Study of KZR-616 during the Pan American Congress of RheumatologyKezar Highlights Data from MISSION Phase 1b Study of KZR-616 during the Pan American Congress of Rheumatology
finance.yahoo.com - September 17 at 8:35 PM
Kezar Life Sciences to Present at The Myositis Association International Annual Patient Conference and the Pan-American Congress of RheumatologyKezar Life Sciences to Present at The Myositis Association International Annual Patient Conference and the Pan-American Congress of Rheumatology
finance.yahoo.com - September 10 at 8:11 AM
Kezar Life Sciences: Exploring New Options For Autoimmune DiseasesKezar Life Sciences: Exploring New Options For Autoimmune Diseases
seekingalpha.com - September 7 at 1:41 PM
Kezar Life Sciences, Inc. (KZR)Kezar Life Sciences, Inc. (KZR)
uk.finance.yahoo.com - September 6 at 6:55 PM
Kezar Life Sciences to Participate in Upcoming Virtual Investor ConferencesKezar Life Sciences to Participate in Upcoming Virtual Investor Conferences
businesswire.com - September 3 at 8:06 PM
Is Kezar Life Sciences, Inc.'s (NASDAQ:KZR) Shareholder Ownership Skewed Towards Insiders?Is Kezar Life Sciences, Inc.'s (NASDAQ:KZR) Shareholder Ownership Skewed Towards Insiders?
finance.yahoo.com - August 11 at 4:59 PM
What Is The Ownership Structure Like For Kezar Life Sciences, Inc. (NASDAQ:KZR)?What Is The Ownership Structure Like For Kezar Life Sciences, Inc. (NASDAQ:KZR)?
finance.yahoo.com - August 11 at 4:59 PM
Kezar Life Sciences, Inc. 2020 Q2 - Results - Earnings Call PresentationKezar Life Sciences, Inc. 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 6 at 7:34 PM
Kezar Life Sciences EPS beats by $0.04Kezar Life Sciences EPS beats by $0.04
seekingalpha.com - August 5 at 6:09 PM
Kezar Life Sciences Reports Second Quarter 2020 Financial Results and Provides Clinical and Business UpdateKezar Life Sciences Reports Second Quarter 2020 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - August 5 at 6:09 PM
Kezar Life Sciences to Participate in Two Upcoming Virtual Investor ConferencesKezar Life Sciences to Participate in Two Upcoming Virtual Investor Conferences
finance.yahoo.com - August 3 at 6:32 PM
Kezar Life Sciences to Release Second Quarter Financial Results and General Business Updates on August 5, 2020Kezar Life Sciences to Release Second Quarter Financial Results and General Business Updates on August 5, 2020
finance.yahoo.com - July 29 at 7:17 PM
Kezar Life Sciences, Inc. (KZR): Hedge Funds In Wait-and-See ModeKezar Life Sciences, Inc. (KZR): Hedge Funds In Wait-and-See Mode
finance.yahoo.com - June 23 at 10:52 PM
Trade Alert: The Independent Director Of Kezar Life Sciences, Inc. (NASDAQ:KZR), Franklin Berger, Has Just Spent US$550k Buying 15% More SharesTrade Alert: The Independent Director Of Kezar Life Sciences, Inc. (NASDAQ:KZR), Franklin Berger, Has Just Spent US$550k Buying 15% More Shares
finance.yahoo.com - June 12 at 10:09 AM
Why Kezar Life Sciences Is Down TodayWhy Kezar Life Sciences Is Down Today
finance.yahoo.com - June 9 at 5:46 PM
Is This Flaming Hot Biotech Stock a Buy?Is This Flaming Hot Biotech Stock a Buy?
finance.yahoo.com - June 9 at 12:46 PM
Kezar Announces Proposed Public Offering of Common StockKezar Announces Proposed Public Offering of Common Stock
finance.yahoo.com - June 8 at 10:16 AM
Stock Alert : Kezar Life Up 89%Stock Alert : Kezar Life Up 89%
www.nasdaq.com - June 4 at 3:15 PM
Kezar up big on positive KZR-616 dataKezar up big on positive KZR-616 data
seekingalpha.com - June 4 at 10:15 AM
Stocks Making Big Moves After Hours: Kezar Life Sciences, Smartsheet, Cloudera, ZuoraStocks Making Big Moves After Hours: Kezar Life Sciences, Smartsheet, Cloudera, Zuora
www.nasdaq.com - June 3 at 11:02 PM
Kezar Provides Data Update from MISSION Study of KZR-616Kezar Provides Data Update from MISSION Study of KZR-616
finance.yahoo.com - June 3 at 6:01 PM
Kezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare ConferenceKezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 28 at 5:37 PM
Why Earnings Season Could Be Great for Kezar Life Sciences (KZR)Why Earnings Season Could Be Great for Kezar Life Sciences (KZR)
finance.yahoo.com - May 11 at 4:01 PM
Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business UpdateKezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - May 7 at 6:48 PM
Kezar Life Sciences: Key Catalysts AheadKezar Life Sciences: Key Catalysts Ahead
seekingalpha.com - May 7 at 1:47 PM
Kezar Life Sciences Strengthens Executive Team with the Appointment of Noreen R. Henig, MD as Chief Medical OfficerKezar Life Sciences Strengthens Executive Team with the Appointment of Noreen R. Henig, MD as Chief Medical Officer
finance.yahoo.com - May 4 at 4:20 PM
Kezar Provides Statement Regarding COVID-19 PandemicKezar Provides Statement Regarding COVID-19 Pandemic
finance.yahoo.com - April 9 at 9:11 AM
Is Kezar Life Sciences (KZR) Stock Outpacing Its Medical Peers This Year?Is Kezar Life Sciences (KZR) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - March 24 at 1:06 PM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.